Entrada Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $20k | 1.9k | 10.28 |
| 2025-09-30 | $43k | 7.4k | 5.80 |
| 2025-06-30 | $26k | 3.9k | 6.72 |
| 2025-03-31 | $11k | 1.2k | 9.04 |
| 2024-12-31 | $27k | 1.5k | 17.29 |
| 2024-09-30 | $102k | 6.4k | 15.98 |
| 2024-06-30 | $41k | 2.9k | 14.25 |
| 2024-03-31 | $6.2k | 435 | 14.17 |
| 2023-09-30 | $16k | 1.0k | 15.78 |
| 2023-06-30 | $9.0k | 594 | 15.14 |
| 2023-03-31 | $19k | 1.3k | 14.71 |
| 2022-12-31 | $6.0k | 447 | 13.42 |
| 2022-09-30 | $40k | 2.5k | 15.95 |
| 2022-03-31 | $23k | 2.5k | 9.26 |
| 2021-12-31 | $42k | 2.5k | 16.95 |